Melanoma — Trials · CancerIndex

Clinical trials

Registered studies

3,221 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 605
Recruiting: 316
Ph III recruiting: 30
Growth YoY: +37.2%
Industry share: 33%
Top sponsor: M.D. Anderson Cancer Center
Termination share: 37.5%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (571)

clinicaltrialsPublishedShowing 301–338 of 338 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT01620749	Of 18F MEL050 Using PET/CT in Metastatic Melanoma(MEL050)	unknown	Early Phase 1	12	Cooperative Research Centre for Biomedical Imaging DevelopmentOTHER	1	Jun 15, 2012	clinicaltrials
NCT01614301	Phase I and Consecutive Phase II, Two-arm, Randomized Multi-center Trial in Patients With Advanced Melanoma	unknown	Phase 1 / Phase 2	136	University of RegensburgOTHER	1	Jun 7, 2012